Global biotherapeutics leader CSL Behring announced that the U.S. Food and Drug Administration (FDA) has approved P...
US based Bristol-Myers Squibb Company and Halozyme Therapeutics, Inc. has announced a global collaboration and lice...
Combined business delivers world-leading imaging capabilities to drive improved decision-making from early drug discover...
Germany based Boehringer Ingelheim has committed up to €250 million ($300 million) to work with Gubra on ...
Singapore - The steady march of progress in new treatments for patients with acute myeloid leukemia (AML), one of the de...
In a bid to speed up drug discovery process and boost R&D efforts, Korea Pharmaceutical and Bio-pharma Manufacturers...
Singapore – The U.S. Food and Drug Administration (FDA) announced the approval of a new, cutting-edge gene therapy...
Singapore- The U.S. Food and Drug Administration today approved Besponsa (inotuzumab ozogamicin) for the treatment of ad...
Singapore - Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (N...
Singapore: It’s estimated that, on average, to bring one new drug to the market can take 1,000 people, 12-15 years...
Singapore - Cardiovascular diseases including heart diseases and stroke account for one-third of deaths (nearly 18 milli...
Japanese pharma giant Takeda pharmaceuticals has entered into a strategic licensing deal with US’s Tesaro fo...
A year since launching, the international partnership CARB-X announced its second round of antibiotic research and ...
The Catalent Applied Drug Delivery Institute has announced Jim Spavins to their advisory board. He has over 36 years of...
The field of drug delivery is highly interdisciplinary. This science of delivering a pharmaceutical compound in the huma...
Singapore: In a bid to spur the country’s drug development and research, South Korea’s leading biopharmaceu...
Singapore - GSK announced that the US Food and Drug Administration (FDA) has approved a new subcutaneous formulatio...
Singapore - The U.S. Food and Drug Administration approved Nerlynx (neratinib) for the extended adjuvant treatment of ea...
